Short term efficacy of vital pulp preservation therapy for symptomatic irreducible pulpitis and its influence on the mental state of patients

Abstract

Objective To look into the short-term effectiveness of pulpal preservation therapy for symptomatic irreducible pulpitis and how it affects patients' mental health. Methods Between July 2019 and July 2022, two hundred individuals with symptomatic irreducible pulpitis who sought treatment at our institution will serve as the study subjects. Fifty patients were assigned to each of four groups (A, B, C, and D) based on a random number table, with each group receiving either indirect pulp capping, direct pulp capping, partial pulpotomy, or total pulpotomy. The short-term effectiveness, Visual analogue scoring (VAS), self-rating anxiety scale (SAS), and self-rating depression scale (SDS) scores, and Oral health-related quality of life (OHRQoL) score of the four groups were monitored for 3 months. Results Of the 200 patients with symptomatic irreducible pulpitis, 185 responded well to vital pulp preservation therapy, while 15 did not; the total success rate was 92.50%, and there was no significant difference between the four groups (P>0.05); The VAS scores of all four groups fell considerably (P<0.05) after therapy compared to before treatment, although there was no significant difference between the groups (P>0.05); SAS and SDS scores for all four groups improved considerably after therapy compared to pre-treatment levels (P<0.05), but there was no significant difference between the groups (P>0.05); Overall, all four groups had decreases in their OHRQoL scores after therapy compared to pre-treatment levels (P<0.05), although there was no significant difference across the groups (P>0.05). Conclusion The clinical reference value of vital pulp preservation treatment for symptomatic irreducible pulpitis is high, and it has a large short-term effect, which can significantly reduce the pain level of patients, improve their mental condition, and enhance their quality of life.